Home > Specialists > Urology > Dr. Bo Dai (戴波)
Specialty & Clinical Focus:
Urological oncology specialist and Director of Urology at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on prostate, kidney, bladder, testicular, penile and adrenal tumors, including robotic-assisted and other minimally invasive surgery.
Professional Title & Qualifications:
Chief Physician
Professor
Doctoral Supervisor
MD
PhD
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Urology
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Bo Dai (戴波) - Urological Oncology Specialist
Personal Biography
Dr. Bo Dai is a Chief Physician, Professor and Director of the Department of Urology at Fudan University Shanghai Cancer Center (FUSCC). He holds an MD and PhD in Oncology from Fudan University and completed clinical observer training at Memorial Sloan Kettering Cancer Center in New York.
His practice focuses on urological oncology, particularly prostate cancer, including early diagnosis, robotic-assisted radical prostatectomy, nerve-sparing surgery and management of advanced disease. He also has experience in nephron-sparing surgery for kidney cancer, bladder cancer surgery and other urological tumors. Dr. Dai leads FUSCC’s multidisciplinary team for genitourinary cancers and is involved in research and clinical trials related to precision medicine in prostate cancer.
Why Choose Dr. Bo Dai for Your Urological Oncology Care?
Dr. Bo Dai combines his role as Director of Urology at Fudan University Shanghai Cancer Center with focused experience in prostate, kidney and bladder cancers. His clinical observer experience at Memorial Sloan Kettering Cancer Center and leadership of FUSCC’s genitourinary cancer multidisciplinary team support a multidisciplinary approach to complex cases, including metastatic castration-resistant prostate cancer (mCRPC).
For international patients considering care in Shanghai, a remote specialist review can help clarify the records, imaging, pathology reports, previous treatment history and questions that should be prepared before travel. Dr. Dai’s experience in Da Vinci robotic-assisted radical prostatectomy, nerve-sparing surgery, nephron-sparing kidney surgery and other minimally invasive procedures makes his profile particularly relevant to patients seeking specialist input on surgical and multidisciplinary treatment options.
Pre-Travel Case Review & Specialist Liaison
Before making travel arrangements, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Dai. We organise medical-record preparation, translation coordination, client-authorized secure document transfer and appointment communication with the relevant third-party specialist office.
Once the remote specialist review has been accepted and confirmed, Dr. Dai or the relevant specialist team will review the submitted records and provide a clinical opinion, recommendations and responses to the patient’s submitted questions. MedBridgeNZ can then coordinate appointment requests and practical travel planning if the patient chooses to pursue care in Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Bo Dai
Areas of Expertise
Prostate Cancer: Early diagnosis, robotic-assisted radical prostatectomy, nerve-sparing surgery, and comprehensive management of metastatic castration-resistant prostate cancer (mCRPC).
Kidney Cancer: Laparoscopic and robotic partial nephrectomy (nephron-sparing surgery) and treatment of advanced renal cell carcinoma.
Bladder Cancer: Radical cystectomy and urinary diversion.
Other Urological Tumors: Diagnosis and treatment of testicular cancer, penile cancer, and adrenal tumors.
Minimally Invasive Surgery: Proficient in Da Vinci robotic surgery and laparoscopic procedures.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
15,900 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Director: Department of Urology, Fudan University Shanghai Cancer Center.
Chief Physician & Professor: Department of Urology, Fudan University Shanghai Cancer Center (2015 – Present).
Deputy Chief Physician: Department of Urology, Fudan University Shanghai Cancer Center (2010 – 2015).
Attending Urologist: Department of Urology, Fudan University Shanghai Cancer Center (2006 – 2010).
Clinical Observer: Memorial Sloan-Kettering Cancer Center, New York (2009).
Education & Training
MD and PhD in Oncology, Fudan University.
Clinical Observer training, Memorial Sloan-Kettering Cancer Center, New York (2009).
Awards & Honors
Shanghai Science and Technology Progress Award: First Prize.
Shanghai Medical Science and Technology Award: First Prize.
Chinese Medical Science and Technology Award: Second Prize.
Top Ten Young Doctors: Fudan University.
Outstanding Young Talent Training Plan: Shanghai Municipal Commission of Health & Family Planning.
Influential Man of the Year: Shanghai Urological Association.
Academic & Professional Memberships
Vice Director & Secretary-General: Integrated Prostate Cancer Committee, China Anti-Cancer Association (CACA).
Vice Chairman: Genitourinary Tumor Integrated Rehabilitation Committee, CACA.
Standing Committee Member & Secretary-General: Male Genital Tumor Committee, CACA.
Committee Member: Clinical Research Committee, Asian Robotic Urological Society.
Standing Committee Member: Endoscopy and Laparoscopy Surgery Branch, China International Exchange and Promotive Association for Medical and Health Care.
Member: Urology Medical Expert Committee, China Industry-University-Research Institute Collaboration Association.
Research & Publications
Project Leadership: Principal Investigator for over 6 major research grants, including projects funded by the National Natural Science Foundation of China and Shanghai municipal foundations.
Publications: Published more than 50 original articles in peer-reviewed journals as first author or corresponding author, including journals such as Cell Research, Cancer Cell, and Clinical Cancer Research.
Clinical Trials: Leading principal investigator for multiple international and national multicenter clinical trials focusing on genitourinary cancers.
Patents: Holds national patents related to urological surgical devices and diagnostic methods.
Selected Peer-Reviewed Publications
Selected peer-reviewed publications involving Dr. Bo Dai:
Wei Y et al. Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. Mol Oncol. 2023;17(10):2183–2199. PMID: 37584393
Wei Y et al. Germline DNA Repair Gene Mutation Landscape in Chinese Prostate Cancer Patients. Eur Urol. 2019;76(3):280–283. PMID: 31248605
Lin GW et al. Clinical activity of abiraterone plus prednisone in docetaxel-naïve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer. Asian J Androl. 2019;21(2):131–136. PMID: 30560837
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Dai’s expertise relevant to my prostate cancer diagnosis?
Dr. Dai’s clinical focus covers early-stage and advanced prostate cancer, including robotic-assisted radical prostatectomy, nerve-sparing surgery and management of metastatic castration-resistant prostate cancer (mCRPC). MedBridgeNZ can coordinate a remote specialist-review request to explore whether his expertise is relevant to your case. After the review request is accepted and confirmed, Dr. Dai or the relevant specialist team will review your records and questions and provide a clinical opinion and recommendations before you decide whether to pursue further care in Shanghai.
What support is available if I travel to Shanghai for urological care?
If you choose to pursue an onsite pathway, MedBridgeNZ can assist with appointment request coordination at Fudan University Shanghai Cancer Center, medical invitation or visa-document coordination support, travel planning, accommodation coordination, translation coordination and non-clinical bilingual administrative support during hospital visits. The exact arrangements depend on hospital scheduling, the patient’s travel requirements and the services separately requested.
Which advanced surgical techniques are included in Dr. Dai’s clinical focus?
Dr. Dai’s stated areas of expertise include Da Vinci robotic-assisted and laparoscopic procedures, robotic-assisted radical prostatectomy, nerve-sparing prostate surgery, partial nephrectomy for kidney cancer, and radical cystectomy with urinary diversion for bladder cancer. Whether a particular surgical technique is relevant to an individual patient depends on the specialist’s review of the diagnosis, imaging, pathology findings, previous treatment and overall clinical circumstances.
How can I request remote specialist-review coordination with Dr. Dai from outside China?
Contact MedBridgeNZ with your diagnosis, available medical records and the questions you would like the specialist to address. With your authorization, we coordinate record preparation, translation support, secure document transfer and communication with the relevant specialist office. Once the remote review is accepted and confirmed, Dr. Dai or the relevant specialist team will review the submitted materials and provide the clinical opinion and recommendations. MedBridgeNZ can then assist with the administrative and travel steps you choose to pursue.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment. Hospital, specialist and other third-party medical or travel costs are separate from MedBridgeNZ coordination fees unless expressly stated otherwise in writing.